title: Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.
abstract: Choline PET/CT has shown limitations for the detection of primary prostate cancer and nodal metastatic disease, mainly due to limited sensitivity and specificity. Conversely in the restaging of prostate cancer recurrence, choline PET/CT is a promising imaging modality for the detection of local regional and nodal recurrence with an impact on therapy management. This review highlights current literature on choline PET/CT for radiation treatment planning in primary and recurrent prostate cancer. Due to limited sensitivity and specificity in differentiating between benign and malignant prostatic tissues in primary prostate cancer, there is little enthusiasm for target volume delineation based on choline PET/CT. Irradiation planning for the treatment of single lymph node metastases on the basis of choline PET/CT is controversial due to its limited lesion-based sensitivity in primary nodal staging. In high-risk prostate cancer, choline PET/CT might diagnose lymph node metastases, which potentially can be included in the conventional irradiation field. Prior to radiation treatment of recurrent prostate cancer, choline PET/CT may prove useful for patient stratification by excluding distant disease which would require systemic therapy. In patients with local recurrence, choline PET/CT can be used to delineate local sites of recurrence within the prostatic resection bed allowing a boost to PET-positive sites. In patients with lymph node metastases outside the prostatic fossa and regional metastatic lymph nodes, choline PET/CT might influence radiation treatment planning by enabling extension of the target volume to lymphatic drainage sites with or without a boost to PET-positive lymph nodes. Further clinical randomized trials are required to assess treatment outcomes following choline-based biological radiation treatment planning in comparison with conventional radiation treatment planning.
authors.affiliation: Department of Nuclear Medicine, University Medical Centre Rostock, Rostock, Germany.
authors.forename: S M
authors.initials: SM
authors.lastname: Schwarzenböck
authors.forename: J
authors.initials: J
authors.lastname: Kurth
authors.forename: Ch
authors.initials: Ch
authors.lastname: Gocke
authors.forename: T
authors.initials: T
authors.lastname: Kuhnt
authors.forename: G
authors.initials: G
authors.lastname: Hildebrandt
authors.forename: B J
authors.initials: BJ
authors.lastname: Krause
mesh_terms: D002794:Choline; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D008297:Male; D064847:Multimodal Imaging; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000532:radiotherapy; D061089:Radiotherapy, Image-Guided; D014057:Tomography, X-Ray Computed
chemical_list: D002794:Choline